Outcomes of rare patients with a primary cutaneous CD30+ lymphoproliferative disorder developing extracutaneous disease.
Melchers RC, Willemze R, Vermaat JSP, Jansen PM, Daniëls LA, Putter H, Bekkenk MW, de Haas ERM, Horvath B, van Rossum MM, Sanders CJG, Veraart JCJM, Vermeer MH, Quint KD.
Melchers RC, et al. Among authors: jansen pm.
Blood. 2020 Mar 5;135(10):769-773. doi: 10.1182/blood.2019002799.
Blood. 2020.
PMID: 31977038
Free article.
No abstract available.